Patent Cliff Has Drug Companies On Deal Hunt: Report

The looming prospect of health care reforms and the upcoming expiration of a number of drug patents by 2012 are fueling consolidation in the pharmaceutical industry, with many more companies pushing...

Already a subscriber? Click here to view full article